Laiqa Wellness has successfully secured Rs 15 crore (approximately USD 1.8 million) in a fresh round of funding. The investment comes from IvyCap Ventures, a prominent early-stage venture capital firm, signalling a vote of confidence in Laiqa’s innovative approach to women’s hormonal health.

The funding is set to drive Laiqa’s expansion and enhance its technology-driven solutions. These include personalised hormonal health monitoring, point-of-care assessments, and AI-powered recommendations, all aimed at addressing hormonal imbalances.

Founded just over a year ago in August 2023 by Monica Bindra, Harmeet Bindra, and Meenakshi Singh, Laiqa Wellness is focused on revolutionising women’s wellness. The company’s offerings cater to various conditions associated with hormonal imbalances, such as PCOS, thyroid disorders, insulin resistance, sleep issues, and other lifestyle-related health concerns. By utilising a cycle-synced approach, Laiqa’s app supports users with tailored diets, fitness routines, and herbal remedies to promote better health outcomes.

IvyCap Ventures, established in 2011, is no stranger to backing innovative startups across diverse sectors, including healthtech, consumer tech, deeptech, fintech, edtech, agritech, and spacetech. Earlier this year, the venture capital firm closed its third fund at Rs 2,100 crore (about USD 252 million), with plans to invest in around 25 early-stage startups.